Vito Amodio
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Genetic factors in colorectal cancer 9
- Vitamin D Research Studies 1
- Oncology 9
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- Alberto Bardelli (8 shared papers)Giovanni Germano (8 shared papers)Federica Di Nicolantonio (4 shared papers)Simona Lamba (3 shared papers)Rosaria Chilà (3 shared papers)Monica Montone (2 shared papers)Annalisa Lorenzato (2 shared papers)Alessandro Magrì (2 shared papers)
- Journals
- Cancer Discovery (3 papers)Cancer Cell (2 papers)Science Translational Medicine (1 paper)Science (1 paper)Cancer Research (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Vito Amodio
12 papers receiving 1.2k citations
Vito Amodio's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 524
- Cancer Research 248
- Pathology and Forensic Medicine 220
- Molecular Biology 471
- Immunology 125
Countries citing papers authored by Vito Amodio
This map shows the geographic impact of Vito Amodio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Amodio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Amodio more than expected).
Fields of papers citing papers by Vito Amodio
This network shows the impact of papers produced by Vito Amodio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Amodio. The network helps show where Vito Amodio may publish in the future.
Co-authors
The 25 scholars most cited alongside Vito Amodio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer Hit paper breakdown → | 2020 | 391 |
| 2 | 2019 | 329 | |
| 3 | 2020 | 223 | |
| 4 | 2021 | 59 | |
| 5 | 2021 | 56 | |
| 6 | 2019 | 46 | |
| 7 | 2022 | 31 | |
| 8 | 2023 | 17 | |
| 9 | 2024 | 12 | |
| 10 | 2025 | 12 | |
| 11 | 2021 | 7 | |
| 12 | 2025 | 2 | |
| 13 | 2026 | 0 |
About Vito Amodio
Vito Amodio is a scholar working on Pathology and Forensic Medicine, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Ferroptosis and cancer prognosis (2 papers), DNA Repair Mechanisms (2 papers), Vitamin D Research Studies (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (524 citations), Cancer Research (248 citations), Pathology and Forensic Medicine (220 citations), Molecular Biology (471 citations) and Immunology (125 citations). Vito Amodio has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Alberto Bardelli, Giovanni Germano, Federica Di Nicolantonio, Simona Lamba, Rosaria Chilà, Monica Montone, Annalisa Lorenzato, Alessandro Magrì, Sergio Abrignani and Maurizio D’Incalci. Their work appears in journals such as Cancer Discovery, Cancer Cell, Science Translational Medicine, Science and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.